LeMaitre Vascular plans to price public offering of its common shares

Canaccord Genuity and Stifel will be the joint bookrunning managers

By Devika Patel

Knoxville, Tenn., May 29 - LeMaitre Vascular, Inc. said it will price a public sale of common shares with a 30-day 15% greenshoe option.

Canaccord Genuity and Stifel are the joint bookrunners.

Proceeds will be used for general corporate purposes, including product development, working capital and capital expenditures.

The Burlington, Mass., company develops medical devices and implants for the treatment of peripheral vascular disease.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.